Advancing Anti-Influenza API Production through Enantioselective Catalysis and High-Purity Chiral Intermediates
This article explores the evolution of chiral drug synthesis through enantioselective catalysis, highlighting its critical role in ensuring the safety and efficacy of high-purity intermediates for anti-influenza APIs.






